Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Significant Decline in Short Interest

Autonomix Medical, Inc. (NASDAQ:AMIXGet Free Report) was the target of a large decline in short interest during the month of February. As of February 28th, there was short interest totalling 75,900 shares, a decline of 23.9% from the February 13th total of 99,700 shares. Approximately 4.4% of the company’s stock are sold short. Based on an average daily trading volume, of 347,600 shares, the days-to-cover ratio is presently 0.2 days.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Autonomix Medical stock. Citadel Advisors LLC bought a new position in shares of Autonomix Medical, Inc. (NASDAQ:AMIXFree Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 47,884 shares of the company’s stock, valued at approximately $180,000. Citadel Advisors LLC owned about 4.16% of Autonomix Medical at the end of the most recent quarter. Hedge funds and other institutional investors own 10.78% of the company’s stock.

Autonomix Medical Trading Down 9.8 %

Shares of Autonomix Medical stock opened at $1.85 on Monday. The company has a fifty day simple moving average of $2.77 and a 200-day simple moving average of $7.24. The stock has a market cap of $4.56 million, a price-to-earnings ratio of -0.14 and a beta of -5.40. Autonomix Medical has a 12-month low of $1.83 and a 12-month high of $75.80.

Autonomix Medical (NASDAQ:AMIXGet Free Report) last announced its quarterly earnings results on Thursday, February 13th. The company reported ($1.46) earnings per share for the quarter. On average, analysts forecast that Autonomix Medical will post -10 earnings per share for the current fiscal year.

About Autonomix Medical

(Get Free Report)

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.

Featured Stories

Receive News & Ratings for Autonomix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autonomix Medical and related companies with MarketBeat.com's FREE daily email newsletter.